Brief: Bavarian Nordic, Serum Institute Of India Expand Strategic Partnership
11/03/2026 07:51
March 11 (Reuters) - Bavarian Nordic A/S BAVA.CO: BAVARIAN NORDIC AND SERUM INSTITUTE OF INDIA EXPAND STRATEGIC PARTNERSHIP WITH CHIKUNGUNYA VACCINE MANUFACTURING AGREEMENT AGREEMENT ENABLES FUTURE SUPPLY OF CHIKUNGUNYA VACCINE TO LOW- AND MIDDLE-INCOME COUNTRIES AGREEMENT REPLACES PREVIOUS DEAL WITH BIOLOGICAL E. LIMITED Source text: ID:nGNE6RGs2y Further company coverage: BAVA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Gets Smallpox/Mpox Vaccine Supply Contract
Brief: Bavarian Nordic Secures Additional Government Contract For The Supply Of Smallpox/Mpox Vaccine
Brief: Bavarian Nordic Launches Final Tranche Of Buy-Back Program
Bavarian Nordic falls as high costs, lower vaccine sales hit Q1 results
Bavarian Nordic Q1 revenue falls as Public Preparedness unit sales decline